Visualitza Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per autor "Yang, James Chih-Hsin"
Ara mostrant els elements 1-5 d 5
-
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1–Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial
Westeel, Virginie; ÖZGÜROGLU, MUSTAFA; Reck, Martin; Barlesi, Fabrice; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Elsevier, 2024-02) -
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
Yang, James Chih-Hsin; Jänne, Pasi A.; Ramalingam, Suresh; Kim, Tae Min; Riely, Gregory; FELIP, ENRIQUETA; Zhou, Caicun (Taylor & Francis, 2023) -
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
yu, helena; Goto, Yasushi; Hayashi, Hidetoshi; FELIP, ENRIQUETA; Yang, James Chih-Hsin; Reck, Martin (American Society of Clinical Oncology, 2023-12-10) -
HERTHENA-Lung01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic EGFR-mutated NSCLC
Yu, Helena A; Hayashi, Hidetoshi; Goto, Yasushi; Reck, Martin; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Future Medicine, 2023-06) -
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC
Levy, Benjamin; Cappuzzo, Federico; Yoneshima, Yasuto; Reck, Martin; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Future Medicine, 2023-07)